Testing a glowing dye to find nervous system tumor tissue
Part of Brain & nervous system, Cancer clinical trials.
This early (Phase 1) study tests whether a glowing dye called indocyanine green helps surgeons better see nervous system tumor tissue during an operation, with the goal of lowering the chance of tumor coming back locally. It’s for adults whose tumor is expected to be removable and at risk for local recurrence.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 or older.
- Your doctor thinks you have a nervous system tumor that can likely be surgically removed.
- Your surgical team (doctors and specialists working together) believes you are a good candidate for surgery.
- You are able to understand the study and sign informed consent.
- You are not pregnant around the time of surgery (pregnancy testing within 48 hours).
- You have no known allergy to iodide (iodine-containing allergy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
This study uses a special dye that makes tumors glow during surgery, helping your surgeon see exactly what to remove and what to leave. It aims to make surgery more precise and safer for people with bone or soft tissue tumors.
This trial tests a special imaging tool that helps surgeons see brain tumors more clearly during surgery, so they can remove as much tumor as possible while protecting healthy tissue. It is designed for people already having surgery to remove a brain tumor.
This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.
This study tests whether a special dye (ICG) injected before surgery can help surgeons see head and neck cancer more clearly during the operation. It is for people with squamous cell carcinoma who are at risk of their cancer returning and are scheduled for surgery.
Hear when a new Nervous System Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.